Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
866K
-
Shares change
-
-945K
-
Total reported value, excl. options
-
$1.38M
-
Value change
-
-$906K
-
Put/Call ratio
-
0.42
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$1.59
Significant Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q3 2022
21 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q3 2022.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 866K shares
of 101M outstanding shares and own 0.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (406K shares), BlackRock Inc. (83.7K shares), GEODE CAPITAL MANAGEMENT, LLC (78.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (72.2K shares), Virtu Financial LLC (46.1K shares), CITADEL ADVISORS LLC (40.2K shares), RAYMOND JAMES & ASSOCIATES (33K shares), SABBY MANAGEMENT, LLC (30K shares), SIMPLEX TRADING, LLC (22.1K shares), and JANE STREET GROUP, LLC (17.2K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.